Electromagnetic Pelvic Floor Stimulation Versus Biofeedback-Assisted and Conventional Pelvic Floor Muscle Training in Men With Lifelong Premature Ejaculation: A Randomized Controlled Trial

What this Trial Is About

Researchers are evaluating three pelvic floor-based treatments for men with lifelong premature ejaculation, a common male sexual condition that can affect quality of life and relationships. The trial compares electromagnetic pelvic floor stimulation, biofeedback-assisted pelvic floor muscle training, and conventional pelvic floor muscle training. Men aged 18 to 50 years with an intravaginal ejaculatory latency time of less than 1 minute will participate. The study is randomized and controlled to determine which treatment may improve ejaculatory control. Participants will be randomly assigned to one of three groups: electromagnetic pelvic floor stimulation delivered non-invasively over 6 weeks, supervised biofeedback-assisted pelvic floor muscle training over 6 weeks to enhance muscle awareness and coordination, or conventional pelvic floor muscle training over 6 weeks following institutional protocols. Each treatment aims to improve pelvic floor muscle function and ejaculatory control. During the study, men will undergo baseline assessments including medical and sexual history, physical exams, stopwatch measurements of ejaculatory latency time, and questionnaires about sexual function and satisfaction. Outcomes will be measured at baseline, after 6 weeks of treatment, and at 3 months follow-up. Researchers will monitor treatment adherence and any adverse events throughout the trial, focusing on changes in ejaculatory latency time and patient-reported outcomes.

Pelvic Floor Therapies for Lifelong Premature Ejaculation